Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Falcke, Martin Prof. Dr. (15) Hinz, Michael Dr. (2) Janz, Martin Dr. (4) Pezzutto, Antonio Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (3) (-) Kettenmann, Helmut Prof. Dr. (1) (-) Mathas, Stephan Dr. (11) (-) Biologie maligner Lymphome (11) Entwicklungsneurobiologie (1) Mathematische Modellierung zellulärer Prozesse (3) (-) Mathematische Zellphysiologie (1) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (1) Zelluläre Neurowissenschaften (29) 1999 (1) 2000 (1) 2001 (1) (-) 2002 (5) 2003 (1) 2004 (2) 2005 (2) 2006 (4) (-) 2007 (3) 2008 (6) 2009 (3) (-) 2010 (4) 2011 (5) 2012 (1) 2013 (1) 2014 (2) 2015 (5) 2016 (2) 2017 (3) 2018 (2) 2019 (2) 2020 (3) 2021 (3) 2022 (4) 2023 (9) 2024 (1) 12 Ergebnisse: Active Filter: Kettenmann, Helmut Prof. Dr.Mathas, Stephan Dr.Biologie maligner LymphomeMathematische Zellphysiologie200220072010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit 05. August 2010 / PLoS Comput Biol Calcium signals driven by single channel noise A. Skupin H. Kettenmann M. Falcke 01. November 2010 / Cell Cycle Repeat-element driven activation of proto-oncogenes in human malignancies B. Lamprecht C. Bonifer S. Mathas 01. September 2010 / Haematologica Common clonal origin of an acute B lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity R. Ratei M. Hummel I. Anagnostopoulos D. Jaehne R. Arnold B. Doerken S. Mathas B. Thomas O. Dudeck W.D. Ludwig H. Stein 01. Mai 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 01. März 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
05. August 2010 / PLoS Comput Biol Calcium signals driven by single channel noise A. Skupin H. Kettenmann M. Falcke
01. November 2010 / Cell Cycle Repeat-element driven activation of proto-oncogenes in human malignancies B. Lamprecht C. Bonifer S. Mathas
01. September 2010 / Haematologica Common clonal origin of an acute B lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity R. Ratei M. Hummel I. Anagnostopoulos D. Jaehne R. Arnold B. Doerken S. Mathas B. Thomas O. Dudeck W.D. Ludwig H. Stein
01. Mai 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
01. März 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto